Email: patientsmap@ssri.com
Social Survey Research Information (SSRI)
Please complete the contact form at: https://www.ssri.com/e/contact_us
Please visit https://research.ssri.co.jp/pmap/pastdata
The B.R.I.D.G.E. TO DATA® team offers assistance on database-related projects, including database landscaping. Some examples of how the team can help your studies succeed include:
Subscribers have access to B.R.I.D.G.E. TO DATA’s proprietary glossary. This list contains definitions of all our 135 Database Fields, as well as all the coding systems used in our profiles. This glossary is continuously updated each time we come across something new regarding a database, as summarized in our profiles.
Download our latest trifold brochure, then share it with colleagues and friends. Contact us for more information.
B.R.I.D.G.E. TO DATA has been utilized in several published studies and cited in relevant textbooks and presentations.
We are also listed on prominent industry websites such as the Drug Safety Research Unit (DSRU), International Society for Pharmacoepidemiology (ISPE), and PsoBest.
Check out the list of citations and website mentions
In today’s newsletter you can read all about our latest website enhancements, updated tutorial videos, new profiles recently added, and a special spring subscription offer Click here to read more!
We are pleased to add these three MHS profiles to our compendium:
Sarit Chehanowitz
Head of Big Data & Business Development
Maccabi Healthcare Services
ISRAEL
Email: chehanow_s@mac.org.il
Email: leopold_e@mac.org.il
1. Cornberg M, Ahumada A, Aghemo A, Andreoni M, Bhagat A, Butrymowicz I, Carmiel M, Chodick G, Conway B, Song Y, Gasbarrini A, Hüppe D, Plaza FJ, Lampertico P, Alonso MLM, Myles L, Persico M, Ramji A, Sarrazin C, Villa E, Weil C, Otano JIU; CREST Study Group. Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study. Adv Ther. 2022 Jul;39(7):3146-3158.
2. Weil C, Mehta D, Koren G, Pinsky B, Samp JC, Chodick G, Shalev V. Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider. J Viral Hepat. 2018 Feb;25(2):144-151.
3. Weil C, Nwankwo C, Friedman M, Kenet G, Chodick G, Shalev V. Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organization. J Med Virol. 2016 Jun;88(6):1044-50.
4. Weil C, Nwankwo C, Friedman M, Shalev V, Chodick G. Real-World Data on Multiple Comorbidities Among Patients With Hepatitis C: Considerations for Patient Care And Prognosis. VOLUME 18, ISSUE 7, PA543, NOVEMBER 01, 2015. Value Health/ISPOR - Open Archive DOI:https://doi.org/10.1016/j.jval.2015.09.1723.
NOTE: For more recent publications, please reach out to the database contacts.
Sarit Chehanowitz
Head of Big Data & Business Development
Maccabi Healthcare Services
ISRAEL
Email: chehanow_s@mac.org.il
Email: leopold_e@mac.org.il
1. Yanover C, Mizrahi B, Kalkstein N, et al. What Factors Increase the Risk of Complications in SARS-CoV-2-Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization. JMIR Public Health Surveill. 2020;6(3):e20872.
For more recent / additional publications, please reach out to the database contacts.
Sarit Chehanowitz
Head of Big Data & Business Development
Maccabi Healthcare Services
ISRAEL
Email: chehanow_s@mac.org.il
Email: leopold_e@mac.org.il
1. Sharman Moser S, Chodick G, Gelerstein S, Barit Ben David N, Shalev V, Stein-Reisner O. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel. BMC Psychiatry. 2022 Aug 11;22(1):541.
2. Jennifer Kertes, MPH (research conducted as part of PhD), Orit Stein Reisner, MD, MBA, Leon Grunhaus, MD, Ronit Nezry, MPH, Tamar Alcalay, MPH, Joseph Azuri, MD, MHA, Yehuda Neumark, PhD, MPH, Comparison of Smoking Cessation Program Registration, Participation, Smoking Cessation Medication Utilization, and Abstinence Rates Between Smokers With and Without Schizophrenia, Schizo-affective Disorder, or Bipolar Disorder, Nicotine & Tobacco Research, 2021; ntab202 (https://doi.org/10.1093/ntr/ntab202)
3. Jennifer Kertes, Yehuda Neumark, Leon Grunhaus & Orit Stein-Reisner (2021) Comparison of Perceptions and Smoking Cessation Experiences Between Smokers With and Without Serious Mental Illness in a Large Health Maintenance Organization, Journal of Dual Diagnosis, 17:4, 284-295.
4. Jennifer Kertes, Orit Stein Reisner, Leon Grunhaus & Yehuda Neumark (2021) The Impact of Smoking Cessation on Hospitalization and Psychiatric Medication Utilization among People with Serious Mental Illness, Substance Use & Misuse, 56:10, 1543-1550.
5. Ben Zaken S, Radomysky Z, Koren G. Association Between Serum Magnesium Levels and Alzheimer's Disease or Mixed Dementia Patients: A Population-Based Retrospective Controlled Study. J Alzheimers Dis Rep. 2020 Sep 28;4(1):399-404.
6. Yanover C, Mizrahi B, Kalkstein N, Marcus K, Akiva P, Barer Y, Shalev V, Chodick G. What Factors Increase the Risk of Complications in SARS-CoV-2-Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization. JMIR Public Health Surveill. 2020 Aug 25;6(3):e20872.
7. Kodesh A, Goldshtein I, Gelkopf M, Goren I, Chodick G, Shalev V. Epidemiology and comorbidity of severe mental illnesses in the community: findings from a computerized mental health registry in a large Israeli health organization. Soc Psychiatry Psychiatr Epidemiol. 2012 Nov;47(11):1775-82.
For more recent publications, please contact database manager or visit https://www.ksminnovation.com/publications/
